Answers are grounded in this paper and cite their sources.
Experimental study demonstrates that cholestyramine increases bile acid excretion and blocks diet-induced cholesterol spikes in rats, highlighting its lipid-lowering mechanisms.
Administration of cholestyramine, a bile acid binding polymer to rats on a normal diet was without effect on plasma or liver cholesterol concentration, but produced a rise in fecal bile acid excretion. These effects were accompanied by an increase in hepatic de novo cholesterol synthesis. Cholestyramine prevented the rise in plasma cholesterol resulting from administration of cholesterol and cholic acid. The fecal bile acids were increased slightly with a marked elevation in the dihydroxycholanic to cholic acid ratio.
No takes yet. Share an insight, caveat, or question.
Huff et al. (1963) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: